Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

‘Polyworking’: Ketika 1 pekerjaan tak lagi cukup

● Kenaikan harga kebutuhan setiap tahun memaksa banyak orang mencari pekerjaan tambahan.● Pekerjaan tambahan yang dimaksud tidak hanya sampingan, tapi dilakukan dengan intensitas yang hamp...

Saat kesalahan karya ilmiah dibiarkan: Penerbit tetap untung, publik yang rugi

● Kesalahan di jurnal ilmiah bisa berdampak besar, tetapi sering lambat dikoreksi.● Sistem penerbitan akademik yang berorientasi keuntungan acap abai akan kesalahan.● Diperlukan refo...

Indonesia pimpin Dewan HAM PBB: Prestise global di tengah problem domestik

Logo PBB dan bendera Indonesia.hapelinium/Shutterstock● Kepemimpinan Indonesia di Dewan HAM PBB sangat ironis di tengah rapor merah penegakan HAM dalam negeri.● Indonesia mencoba menjadi p...